S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

FLGT Fulgent Genetics Inc

17.31

-0.48 (-2.70%)

Nov 15 2024 - Closed

Delayed by 15 minutes

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

Fulgent Genetics (NASDAQ:FLGT)
Historical Stock Chart
From Oct 2024 to Nov 2024

Click Here for more Fulgent Genetics Charts.

Fulgent Genetics (NASDAQ:FLGT)
Historical Stock Chart
From Nov 2023 to Nov 2024

Click Here for more Fulgent Genetics Charts.

Fulgent Genetics Inc News

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Friday 8 November 2024 (1 week ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 8 November 2024 (1 week ago) • Edgar (US Regulatory)

Fulgent Reports Third Quarter 2024 Financial Results
Friday 8 November 2024 (1 week ago) • Business Wire

Fulgent to Participate in Upcoming Conferences
Tuesday 5 November 2024 (2 weeks ago) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Friday 1 November 2024 (2 weeks ago) • Edgar (US Regulatory)

Fulgent Genetics Awarded Contract by the U.S. Department of Veterans Affairs to Provide Hereditary Cancer, Pharmacogenetic and Other Genetic Testing to Veterans1
Thursday 31 October 2024 (2 weeks ago) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 29 October 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 29 October 2024 (3 weeks ago) • Edgar (US Regulatory)

Fulgent to Announce Third Quarter 2024 Financial Results on Friday, November 8, 2024
Thursday 17 October 2024 (4 weeks ago) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 5 September 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 5 September 2024 (2 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Tuesday 3 September 2024 (2 months ago) • Edgar (US Regulatory)

More Fulgent Genetics Inc News Articles

Super Micro Computer

Decentral Life (PK)

Kraig Biocraft Laborator... (QB)

Halozyme Therapeutics

Elite Pharmaceuticals (QB)

CyberFuels (PK)

FuelCell Energy

Moon Equity (PK)

Accredited Solutions (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions